Synonyms: Cortrosyn®
cosyntropin is an approved drug (FDA (1970))
Compound class:
Peptide
Comment: This is a synthetic peptide forming the fully active N-terminal portion of cortocotropin. Like the endogenous peptide, cosyntropin stimulates the adrenal cortex to produce and secrete adrenocortical hormones.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
No information available. |
Summary of Clinical Use |
This drug is primarily used to diagnose adrenal insufficiency. |
Mechanism Of Action and Pharmacodynamic Effects |
This peptide retains full melanocortin 2 receptor activity compared to naturally occurring corticotropin in its ability to stimulate secretion of adrenocortical hormones. |